Patient characteristics | |
---|---|
Gender | |
Male N, (%) | 7 (54.8%) |
Race | |
White | 11 |
Non-white | 2 |
Age at BT diagnosis (median; range) | 4.2 (0.6–12.9) |
Age at screening (median; range) | 11.8 years (9.3–17.9) |
Disease/treatment characteristic | |
BT histology | |
Medulloblastoma | 9 |
Craniopharyngioma | 1 |
Pilocytic astrocytoma | 1 |
Ependymoma | 1 |
Pineoblastoma | 1 |
Cranial radiation dose (median; range) | 55.8 Gray (50.4–60) |
Age at cranial radiation (median; range) | 5.5 years (2.8–13.2) |
Time since radiation (median; range) | 4.9 years (1.9–15.2) |
VP shunt present | 3 |
Chemotherapy treatment | |
Y | 10 |
N | 3 |
Lansky/Karnofsky performance status | 90 (70–100) |